Small Molecule Allosteric Inhibitor of HIPK2 as a Novel Therapy against Kidney Fibrosis.
作者信息
Lee Kyung, Drakas Robert, He John C
机构信息
Icahn School of Medicine at Mount Sinai, New York, New York.
Rila Therapeutics Inc, South San Francisco, California.
出版信息
J Am Soc Nephrol. 2024 Jun 1;35(6):809-811. doi: 10.1681/ASN.0000000000000327. Epub 2024 Feb 7.
Abstract
摘要
相似文献
1
Small Molecule Allosteric Inhibitor of HIPK2 as a Novel Therapy against Kidney Fibrosis.HIPK2的小分子变构抑制剂作为抗肾纤维化的新型疗法
J Am Soc Nephrol. 2024 Jun 1;35(6):809-811. doi: 10.1681/ASN.0000000000000327. Epub 2024 Feb 7.
2
A Novel Inhibitor of Homeodomain Interacting Protein Kinase 2 Mitigates Kidney Fibrosis through Inhibition of the TGF-1/Smad3 Pathway.一种新型同源结构域相互作用蛋白激酶2抑制剂通过抑制TGF-1/Smad3信号通路减轻肾纤维化
J Am Soc Nephrol. 2017 Jul;28(7):2133-2143. doi: 10.1681/ASN.2016080841. Epub 2017 Feb 20.
3
A systems approach identifies HIPK2 as a key regulator of kidney fibrosis.系统方法确定 HIPK2 是肾脏纤维化的关键调节因子。
Nat Med. 2012 Mar 11;18(4):580-8. doi: 10.1038/nm.2685.
4
Recent advances in the development of HIPK2 inhibitors as anti-renal fibrosis agents.新型 HIPK2 抑制剂在抗肾纤维化药物研发中的进展。
Future Med Chem. 2023 Mar;15(5):453-465. doi: 10.4155/fmc-2022-0278. Epub 2023 Apr 4.
5
EGFR drives the progression of AKI to CKD through HIPK2 overexpression.EGFR 通过 HIPK2 的过表达驱动 AKI 向 CKD 的进展。
Theranostics. 2019 Apr 13;9(9):2712-2726. doi: 10.7150/thno.31424. eCollection 2019.
6
HIPK2 C-terminal domain inhibits NF-κB signaling and renal inflammation in kidney injury.HIPK2 羧基末端结构域抑制肾损伤中的核因子κB信号传导和肾脏炎症。
JCI Insight. 2024 Mar 21;9(8):e175153. doi: 10.1172/jci.insight.175153.
7
The antihelmenthic phosphate niclosamide impedes renal fibrosis by inhibiting homeodomain-interacting protein kinase 2 expression.抗蠕虫药磷酸尼氯苯脒通过抑制同源域相互作用蛋白激酶 2 的表达来抑制肾纤维化。
Kidney Int. 2017 Sep;92(3):612-624. doi: 10.1016/j.kint.2017.01.018. Epub 2017 Mar 17.
8
Tubular HIPK2 is a key contributor to renal fibrosis.管状 HIPK2 是肾脏纤维化的关键贡献者。
JCI Insight. 2020 Sep 3;5(17):136004. doi: 10.1172/jci.insight.136004.
9
Homeodomain-interacting protein kinase 2 regulates DNA damage response through interacting with heterochromatin protein 1γ.同源结构域相互作用蛋白激酶2通过与异染色质蛋白1γ相互作用来调节DNA损伤反应。
Oncogene. 2015 Jun;34(26):3463-73. doi: 10.1038/onc.2014.278. Epub 2014 Aug 25.
10
SIRT6 regulates the HIPK2/P53 pathway to reduce oxidative stress and apoptosis to attenuate vancomycin-induced nephrotoxicity.
Mutat Res. 2025 Jan-Jun;830:111897. doi: 10.1016/j.mrfmmm.2024.111897. Epub 2024 Dec 26.
引用本文的文献
1
Editorial: Cell cross-talk in diabetic kidney diseases, volume III.社论：糖尿病肾病中的细胞间通讯，第三卷。
Front Med (Lausanne). 2025 May 30;12:1627354. doi: 10.3389/fmed.2025.1627354. eCollection 2025.
2
JASN: The Next Chapter.《美国肾脏病学会杂志》：新篇章。
J Am Soc Nephrol. 2024 Jun 1;35(6):679-680. doi: 10.1681/ASN.0000000000000378. Epub 2024 May 2.
本文引用的文献
1
Inhibition of HIPK2 protects stress-induced pathological cardiac remodeling.抑制 HIPK2 可保护应激诱导的病理性心脏重构。
EBioMedicine. 2022 Nov;85:104274. doi: 10.1016/j.ebiom.2022.104274. Epub 2022 Sep 28.
2
Novel therapies emerging in oncology to target the TGF-β pathway.肿瘤学中新兴的靶向 TGF-β 通路的新型疗法。
J Hematol Oncol. 2021 Apr 6;14(1):55. doi: 10.1186/s13045-021-01053-x.
3
Diverse Role of TGF-β in Kidney Disease.转化生长因子-β在肾脏疾病中的多种作用
Front Cell Dev Biol. 2020 Feb 28;8:123. doi: 10.3389/fcell.2020.00123. eCollection 2020.
4
Cardiomyocyte Homeodomain-Interacting Protein Kinase 2 Maintains Basal Cardiac Function via Extracellular Signal-Regulated Kinase Signaling.心肌细胞同源异型盒相互作用蛋白激酶 2 通过细胞外信号调节激酶信号维持基础心脏功能。
Circulation. 2019 Nov 26;140(22):1820-1833. doi: 10.1161/CIRCULATIONAHA.119.040740. Epub 2019 Oct 4.
5
HIPK2 is necessary for type I interferon-mediated antiviral immunity.HIPK2 对于 I 型干扰素介导的抗病毒免疫是必要的。
Sci Signal. 2019 Mar 19;12(573):eaau4604. doi: 10.1126/scisignal.aau4604.
6
A Novel Inhibitor of Homeodomain Interacting Protein Kinase 2 Mitigates Kidney Fibrosis through Inhibition of the TGF-1/Smad3 Pathway.一种新型同源结构域相互作用蛋白激酶2抑制剂通过抑制TGF-1/Smad3信号通路减轻肾纤维化
J Am Soc Nephrol. 2017 Jul;28(7):2133-2143. doi: 10.1681/ASN.2016080841. Epub 2017 Feb 20.
7
Synthesis and properties of a selective inhibitor of homeodomain-interacting protein kinase 2 (HIPK2).同源结构域相互作用蛋白激酶2（HIPK2）选择性抑制剂的合成与性质
PLoS One. 2014 Feb 24;9(2):e89176. doi: 10.1371/journal.pone.0089176. eCollection 2014.
8
A systems approach identifies HIPK2 as a key regulator of kidney fibrosis.系统方法确定 HIPK2 是肾脏纤维化的关键调节因子。
Nat Med. 2012 Mar 11;18(4):580-8. doi: 10.1038/nm.2685.
9
High-throughput kinase profiling: a more efficient approach toward the discovery of new kinase inhibitors.高通量激酶分析：一种发现新型激酶抑制剂的更有效方法。
Chem Biol. 2011 Jul 29;18(7):868-79. doi: 10.1016/j.chembiol.2011.05.010.
Zotero 插件